Ciprofloxacin
Product Images NDC 10544-147

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Ciprofloxacin (NDC 10544-147). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Blenheim Pharmacal, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

250mg 06ct (Label Ciprofloxacin Tabs 250mg Bpi(10544 147 06) Cobalt Watson(16252 514 01) Rev0)

250mg 06ct (Label Ciprofloxacin Tabs 250mg Bpi(10544 147 06) Cobalt Watson(16252 514 01) Rev0)
Ciprofloxacin Tablets USP 250mg bottle label showing a quantity of 6 tablets. The label includes the product NDC 10544-147-06 and manufacturer information for Blenheim Pharmacal, Inc. It contains storage instructions and dosage notes with barcode and lot number details.*
FDA Label Image

Structure 1 (Ciprofloxacin Tablets Usp 1)

Structure 1 (Ciprofloxacin Tablets Usp 1)
Chemical structure diagram of Ciprofloxacin hydrochloride monohydrate, showing its key molecular features including a fluorine atom at position 6, a piperazine ring, a cyclopropyl group, and a carboxylic acid moiety.*
FDA Label Image

Structure 2 (Ciprofloxacin Tablets Usp 2)

Structure 2 (Ciprofloxacin Tablets Usp 2)
Chemical structure of ciprofloxacin depicted as a two-ring fused system with attached functional groups including a cyclopropyl group, piperazine ring, fluorine atom, carboxylic acid group, and a ketone.*
FDA Label Image

Imprint 1 (Ciprofloxacin Tablets Usp 3)

Imprint 1 (Ciprofloxacin Tablets Usp 3)
The image shows a portion of packaging or labeling for Ciprofloxacin, displaying the letters "CR" above the number "250," suggesting a 250 mg strength or perhaps a dose form identifier. The label belongs to Blenheim Pharmacal, Inc., as indicated by the product data. This format is typically used on medication packaging to denote drug name and strength.*
FDA Label Image

Imprint 2 (Ciprofloxacin Tablets Usp 4)

Imprint 2 (Ciprofloxacin Tablets Usp 4)
The image shows a carton packaging for Ciprofloxacin oral suspension, labeled as 100 mg per 5 mL. The packaging includes the product's proprietary name, dosage strength, and form. The labeler name Blenheim Pharmacal, Inc. is also visible. The carton appears primarily white with green and blue accents and includes a tamper-evident seal indication.*
FDA Label Image

Imprint 3 (Ciprofloxacin Tablets Usp 5)

Imprint 3 (Ciprofloxacin Tablets Usp 5)
Ciprofloxacin box label showing the proprietary name Ciprofloxacin. The label includes the Blenheim Pharmacal, Inc. name as the labeler. The image displays the product's NDC number as 10544-147. The text on the box is predominantly black and blue on a white background, with a blue circle design to the right.*
FDA Label Image

Imprint 4 (Ciprofloxacin Tablets Usp 6)

Imprint 4 (Ciprofloxacin Tablets Usp 6)
Ciprofloxacin 500 mg tablets packaging label from Blenheim Pharmacal, Inc. The carton prominently displays the brand name Ciprofloxacin, includes the strength of 500 mg, and indicates that the product contains tablets. The label also features the NDC 10544-147 and the manufacturer's name, Blenheim Pharmacal, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.